KR20220039942A - Saccharomyces cerevisiae FT4-4 strain having antioxidant activity and tyrosinase inhibitory activity isolated from blueberry and uses thereof - Google Patents
Saccharomyces cerevisiae FT4-4 strain having antioxidant activity and tyrosinase inhibitory activity isolated from blueberry and uses thereof Download PDFInfo
- Publication number
- KR20220039942A KR20220039942A KR1020200122067A KR20200122067A KR20220039942A KR 20220039942 A KR20220039942 A KR 20220039942A KR 1020200122067 A KR1020200122067 A KR 1020200122067A KR 20200122067 A KR20200122067 A KR 20200122067A KR 20220039942 A KR20220039942 A KR 20220039942A
- Authority
- KR
- South Korea
- Prior art keywords
- strain
- alcohol
- activity
- saccharomyces cerevisiae
- culture solution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 240000004808 Saccharomyces cerevisiae Species 0.000 title claims abstract description 50
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 title claims abstract description 50
- 102000003425 Tyrosinase Human genes 0.000 title claims abstract description 26
- 108060008724 Tyrosinase Proteins 0.000 title claims abstract description 26
- 230000002401 inhibitory effect Effects 0.000 title claims abstract description 21
- 230000003078 antioxidant effect Effects 0.000 title claims abstract description 20
- 240000000851 Vaccinium corymbosum Species 0.000 title description 11
- 235000003095 Vaccinium corymbosum Nutrition 0.000 title description 11
- 235000017537 Vaccinium myrtillus Nutrition 0.000 title description 11
- 235000021014 blueberries Nutrition 0.000 title description 11
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 51
- 238000004519 manufacturing process Methods 0.000 claims abstract description 27
- 150000001412 amines Chemical class 0.000 claims abstract description 24
- 230000000035 biogenic effect Effects 0.000 claims abstract description 24
- LSNNMFCWUKXFEE-UHFFFAOYSA-N Sulfurous acid Chemical compound OS(O)=O LSNNMFCWUKXFEE-UHFFFAOYSA-N 0.000 claims abstract description 22
- 230000000694 effects Effects 0.000 claims abstract description 22
- 235000000346 sugar Nutrition 0.000 claims abstract description 19
- 102000006995 beta-Glucosidase Human genes 0.000 claims abstract description 18
- 108010047754 beta-Glucosidase Proteins 0.000 claims abstract description 18
- 102000004190 Enzymes Human genes 0.000 claims abstract description 17
- 108090000790 Enzymes Proteins 0.000 claims abstract description 17
- 239000013543 active substance Substances 0.000 claims abstract description 5
- 239000000203 mixture Substances 0.000 claims description 24
- 235000014101 wine Nutrition 0.000 claims description 17
- FYGDTMLNYKFZSV-URKRLVJHSA-N (2s,3r,4s,5s,6r)-2-[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](OC2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-URKRLVJHSA-N 0.000 claims description 13
- 229920002498 Beta-glucan Polymers 0.000 claims description 13
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical group NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 claims description 12
- 239000004480 active ingredient Substances 0.000 claims description 12
- 239000012141 concentrate Substances 0.000 claims description 12
- 235000021107 fermented food Nutrition 0.000 claims description 12
- DZGWFCGJZKJUFP-UHFFFAOYSA-N tyramine Chemical compound NCCC1=CC=C(O)C=C1 DZGWFCGJZKJUFP-UHFFFAOYSA-N 0.000 claims description 12
- 239000002537 cosmetic Substances 0.000 claims description 11
- 239000007858 starting material Substances 0.000 claims description 11
- 230000002087 whitening effect Effects 0.000 claims description 10
- 108010046334 Urease Proteins 0.000 claims description 8
- 230000000975 bioactive effect Effects 0.000 claims description 6
- 229960001340 histamine Drugs 0.000 claims description 6
- 229960003732 tyramine Drugs 0.000 claims description 6
- 235000021028 berry Nutrition 0.000 claims description 4
- 239000000463 material Substances 0.000 claims description 2
- 150000008163 sugars Chemical class 0.000 abstract 1
- 235000019441 ethanol Nutrition 0.000 description 41
- 210000004027 cell Anatomy 0.000 description 39
- 238000004458 analytical method Methods 0.000 description 24
- 239000000243 solution Substances 0.000 description 24
- 210000003491 skin Anatomy 0.000 description 21
- 239000002609 medium Substances 0.000 description 20
- 239000007788 liquid Substances 0.000 description 17
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 11
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 11
- 238000000855 fermentation Methods 0.000 description 11
- 230000004151 fermentation Effects 0.000 description 11
- 239000001963 growth medium Substances 0.000 description 11
- 239000000126 substance Substances 0.000 description 11
- 238000002835 absorbance Methods 0.000 description 10
- 239000008103 glucose Substances 0.000 description 10
- 244000005700 microbiome Species 0.000 description 10
- 235000013305 food Nutrition 0.000 description 9
- 239000006210 lotion Substances 0.000 description 9
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 description 8
- 239000000047 product Substances 0.000 description 8
- 235000019216 blueberry extract Nutrition 0.000 description 7
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 6
- 239000006071 cream Substances 0.000 description 6
- 108090000623 proteins and genes Proteins 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 238000012258 culturing Methods 0.000 description 5
- 239000012153 distilled water Substances 0.000 description 5
- 238000004128 high performance liquid chromatography Methods 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 239000000523 sample Substances 0.000 description 5
- 239000006228 supernatant Substances 0.000 description 5
- 108020004414 DNA Proteins 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- 230000032683 aging Effects 0.000 description 4
- 239000003963 antioxidant agent Substances 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 238000009472 formulation Methods 0.000 description 4
- 238000011534 incubation Methods 0.000 description 4
- 238000005259 measurement Methods 0.000 description 4
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 4
- 150000003254 radicals Chemical class 0.000 description 4
- 229960004441 tyrosine Drugs 0.000 description 4
- 108020004463 18S ribosomal RNA Proteins 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- 239000000654 additive Substances 0.000 description 3
- 230000001476 alcoholic effect Effects 0.000 description 3
- 230000010261 cell growth Effects 0.000 description 3
- 238000005119 centrifugation Methods 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 239000007789 gas Substances 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 230000003647 oxidation Effects 0.000 description 3
- 238000007254 oxidation reaction Methods 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- XPDXVDYUQZHFPV-UHFFFAOYSA-N Dansyl Chloride Chemical compound C1=CC=C2C(N(C)C)=CC=CC2=C1S(Cl)(=O)=O XPDXVDYUQZHFPV-UHFFFAOYSA-N 0.000 description 2
- WTDRDQBEARUVNC-LURJTMIESA-N L-DOPA Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-LURJTMIESA-N 0.000 description 2
- 241000186660 Lactobacillus Species 0.000 description 2
- 241000235070 Saccharomyces Species 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 230000005779 cell damage Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 238000001952 enzyme assay Methods 0.000 description 2
- 210000002919 epithelial cell Anatomy 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 235000019253 formic acid Nutrition 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 230000007760 free radical scavenging Effects 0.000 description 2
- 229930182470 glycoside Natural products 0.000 description 2
- 150000002338 glycosides Chemical class 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 229940039696 lactobacillus Drugs 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 230000001766 physiological effect Effects 0.000 description 2
- RWPGFSMJFRPDDP-UHFFFAOYSA-L potassium metabisulfite Chemical compound [K+].[K+].[O-]S(=O)S([O-])(=O)=O RWPGFSMJFRPDDP-UHFFFAOYSA-L 0.000 description 2
- 229940043349 potassium metabisulfite Drugs 0.000 description 2
- 235000010263 potassium metabisulphite Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 239000003642 reactive oxygen metabolite Substances 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 230000000475 sunscreen effect Effects 0.000 description 2
- 239000000516 sunscreening agent Substances 0.000 description 2
- 239000007222 ypd medium Substances 0.000 description 2
- RGZSQWQPBWRIAQ-CABCVRRESA-N (-)-alpha-Bisabolol Chemical compound CC(C)=CCC[C@](C)(O)[C@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-CABCVRRESA-N 0.000 description 1
- 239000001500 (2R)-6-methyl-2-[(1R)-4-methyl-1-cyclohex-3-enyl]hept-5-en-2-ol Substances 0.000 description 1
- OCZVHBZNPVABKX-UHFFFAOYSA-N 1,1-diphenyl-2-(2,4,6-trinitrophenyl)hydrazine;ethanol Chemical compound CCO.[O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1NN(C=1C=CC=CC=1)C1=CC=CC=C1 OCZVHBZNPVABKX-UHFFFAOYSA-N 0.000 description 1
- PKAUICCNAWQPAU-UHFFFAOYSA-N 2-(4-chloro-2-methylphenoxy)acetic acid;n-methylmethanamine Chemical compound CNC.CC1=CC(Cl)=CC=C1OCC(O)=O PKAUICCNAWQPAU-UHFFFAOYSA-N 0.000 description 1
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 1
- PLXMOAALOJOTIY-FPTXNFDTSA-N Aesculin Natural products OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](O)[C@H]1Oc2cc3C=CC(=O)Oc3cc2O PLXMOAALOJOTIY-FPTXNFDTSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 241000203069 Archaea Species 0.000 description 1
- 241000228212 Aspergillus Species 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- WNBCMONIPIJTSB-BGNCJLHMSA-N Cichoriin Natural products O([C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1)c1c(O)cc2c(OC(=O)C=C2)c1 WNBCMONIPIJTSB-BGNCJLHMSA-N 0.000 description 1
- AHMIDUVKSGCHAU-UHFFFAOYSA-N Dopaquinone Natural products OC(=O)C(N)CC1=CC(=O)C(=O)C=C1 AHMIDUVKSGCHAU-UHFFFAOYSA-N 0.000 description 1
- 206010014970 Ephelides Diseases 0.000 description 1
- 230000005526 G1 to G0 transition Effects 0.000 description 1
- ZCOLJUOHXJRHDI-FZHKGVQDSA-N Genistein 7-O-glucoside Natural products O([C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O1)c1cc(O)c2C(=O)C(c3ccc(O)cc3)=COc2c1 ZCOLJUOHXJRHDI-FZHKGVQDSA-N 0.000 description 1
- CJPNHKPXZYYCME-UHFFFAOYSA-N Genistin Natural products OCC1OC(Oc2ccc(O)c3OC(=CC(=O)c23)c4ccc(O)cc4)C(O)C(O)C1O CJPNHKPXZYYCME-UHFFFAOYSA-N 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010019375 Helicobacter infections Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010020843 Hyperthermia Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 108091023242 Internal transcribed spacer Proteins 0.000 description 1
- MLSJBGYKDYSOAE-DCWMUDTNSA-N L-Ascorbic acid-2-glucoside Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)=C1O MLSJBGYKDYSOAE-DCWMUDTNSA-N 0.000 description 1
- AHMIDUVKSGCHAU-LURJTMIESA-N L-dopaquinone Chemical compound [O-]C(=O)[C@@H]([NH3+])CC1=CC(=O)C(=O)C=C1 AHMIDUVKSGCHAU-LURJTMIESA-N 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- 102000003960 Ligases Human genes 0.000 description 1
- 108090000364 Ligases Proteins 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- 240000000249 Morus alba Species 0.000 description 1
- 235000008708 Morus alba Nutrition 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 1
- YCUNGEJJOMKCGZ-UHFFFAOYSA-N Pallidiflorin Natural products C1=CC(OC)=CC=C1C1=COC2=CC=CC(O)=C2C1=O YCUNGEJJOMKCGZ-UHFFFAOYSA-N 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- 208000012641 Pigmentation disease Diseases 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- 241000030064 Saccharomyces cerevisiae NRRL Y-12632 Species 0.000 description 1
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical class [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 1
- 241000219094 Vitaceae Species 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- OEWBEINAQKIQLZ-CMRBMDBWSA-N [(2s)-2-[(2r)-3,4-bis(2-hexyldecanoyloxy)-5-oxo-2h-furan-2-yl]-2-(2-hexyldecanoyloxy)ethyl] 2-hexyldecanoate Chemical compound CCCCCCCCC(CCCCCC)C(=O)OC[C@H](OC(=O)C(CCCCCC)CCCCCCCC)[C@H]1OC(=O)C(OC(=O)C(CCCCCC)CCCCCCCC)=C1OC(=O)C(CCCCCC)CCCCCCCC OEWBEINAQKIQLZ-CMRBMDBWSA-N 0.000 description 1
- 238000011481 absorbance measurement Methods 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 125000003158 alcohol group Chemical group 0.000 description 1
- RGZSQWQPBWRIAQ-LSDHHAIUSA-N alpha-Bisabolol Natural products CC(C)=CCC[C@@](C)(O)[C@@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-LSDHHAIUSA-N 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- FRHBOQMZUOWXQL-UHFFFAOYSA-L ammonium ferric citrate Chemical compound [NH4+].[Fe+3].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O FRHBOQMZUOWXQL-UHFFFAOYSA-L 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000003627 anti-cholesterol Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 238000002792 antioxidant assay Methods 0.000 description 1
- 229960000271 arbutin Drugs 0.000 description 1
- 229940067599 ascorbyl glucoside Drugs 0.000 description 1
- 125000003289 ascorbyl group Chemical group [H]O[C@@]([H])(C([H])([H])O*)[C@@]1([H])OC(=O)C(O*)=C1O* 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 229940055416 blueberry extract Drugs 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 231100000357 carcinogen Toxicity 0.000 description 1
- 239000003183 carcinogenic agent Substances 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 208000037887 cell injury Diseases 0.000 description 1
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 1
- 229960005091 chloramphenicol Drugs 0.000 description 1
- 230000001447 compensatory effect Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000000824 cytostatic agent Substances 0.000 description 1
- 230000001085 cytostatic effect Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- XHCADAYNFIFUHF-TVKJYDDYSA-N esculin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC(C(=C1)O)=CC2=C1OC(=O)C=C2 XHCADAYNFIFUHF-TVKJYDDYSA-N 0.000 description 1
- 229940093496 esculin Drugs 0.000 description 1
- AWRMZKLXZLNBBK-UHFFFAOYSA-N esculin Natural products OC1OC(COc2cc3C=CC(=O)Oc3cc2O)C(O)C(O)C1O AWRMZKLXZLNBBK-UHFFFAOYSA-N 0.000 description 1
- 239000000686 essence Substances 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 229960004642 ferric ammonium citrate Drugs 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 235000019990 fruit wine Nutrition 0.000 description 1
- 239000000417 fungicide Substances 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- ZCOLJUOHXJRHDI-CMWLGVBASA-N genistein 7-O-beta-D-glucoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC(O)=C2C(=O)C(C=3C=CC(O)=CC=3)=COC2=C1 ZCOLJUOHXJRHDI-CMWLGVBASA-N 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 235000021021 grapes Nutrition 0.000 description 1
- 231100001261 hazardous Toxicity 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- PWSKHLMYTZNYKO-UHFFFAOYSA-N heptane-1,7-diamine Chemical compound NCCCCCCCN PWSKHLMYTZNYKO-UHFFFAOYSA-N 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 230000036031 hyperthermia Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 239000000411 inducer Substances 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 239000004313 iron ammonium citrate Substances 0.000 description 1
- 235000000011 iron ammonium citrate Nutrition 0.000 description 1
- GOMNOOKGLZYEJT-UHFFFAOYSA-N isoflavone Chemical compound C=1OC2=CC=CC=C2C(=O)C=1C1=CC=CC=C1 GOMNOOKGLZYEJT-UHFFFAOYSA-N 0.000 description 1
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 description 1
- 235000008696 isoflavones Nutrition 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 238000005304 joining Methods 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 229940069445 licorice extract Drugs 0.000 description 1
- 210000002752 melanocyte Anatomy 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 210000000440 neutrophil Anatomy 0.000 description 1
- 229960003966 nicotinamide Drugs 0.000 description 1
- 235000005152 nicotinamide Nutrition 0.000 description 1
- 239000011570 nicotinamide Substances 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000004792 oxidative damage Effects 0.000 description 1
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 1
- -1 pack Substances 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000001172 regenerating effect Effects 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 239000002453 shampoo Substances 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 230000037380 skin damage Effects 0.000 description 1
- 230000036560 skin regeneration Effects 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 244000000000 soil microbiome Species 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000012086 standard solution Substances 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 125000001493 tyrosinyl group Chemical group [H]OC1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 description 1
- 229940099259 vaseline Drugs 0.000 description 1
- 238000011514 vinification Methods 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 210000005253 yeast cell Anatomy 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/14—Fungi; Culture media therefor
- C12N1/16—Yeasts; Culture media therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9728—Fungi, e.g. yeasts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12G—WINE; PREPARATION THEREOF; ALCOHOLIC BEVERAGES; PREPARATION OF ALCOHOLIC BEVERAGES NOT PROVIDED FOR IN SUBCLASSES C12C OR C12H
- C12G1/00—Preparation of wine or sparkling wine
- C12G1/02—Preparation of must from grapes; Must treatment and fermentation
- C12G1/0203—Preparation of must from grapes; Must treatment and fermentation by microbiological or enzymatic treatment
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/645—Fungi ; Processes using fungi
- C12R2001/85—Saccharomyces
- C12R2001/865—Saccharomyces cerevisiae
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Botany (AREA)
- General Engineering & Computer Science (AREA)
- Public Health (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- Dermatology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
본 발명은 블루베리로부터 분리된 티로시나아제 저해 활성 및 항산화 활성이 있는 사카로마이세스 세레비지애(Saccharomyces cerevisiae) FT4-4 균주 및 이의 용도에 관한 것이다. The present invention relates to a Saccharomyces cerevisiae FT4-4 strain having tyrosinase inhibitory activity and antioxidant activity isolated from blueberries and uses thereof.
우리나라는 고대부터 식품의 제조에 사용되는 발효기술과 숙성기술이 발달해 왔고, 이에 따라 발효기술을 이용한 전통주도 지속적으로 개발되고 있다. 전통주는 제조방법에 따라 크게 전통 증류주와 전통 발효주로 나누어지며, 특히 전통 발효주는 첨가된 재료에 따라 맛과 향이 독특하고 각기 개성적인 기능성을 함유하고 있다. 전통주의 발효에는 사카로마이세스(Saccharomyces) 속, 아스퍼질러스(Aspergillus) 속, 바실러스(Bacillus) 속, 락토바실러스(Lactobacillus) 속 등의 균주들이 사용되고 있는데, 최근에는 이와 같은 발효 균주들의 생리활성을 강조한 건강 기능성 발효주가 생산되고 있다.In Korea, fermentation technology and aging technology used in food production have been developed since ancient times, and traditional wine using fermentation technology has been continuously developed. Traditional liquor is largely divided into traditional distilled liquor and traditional fermented liquor according to the manufacturing method. Saccharomyces ( Saccharomyces ) genus, Aspergillus genus, Bacillus genus, Lactobacillus genus, etc. are used for fermentation of traditional liquor, and recently, the physiological activity of these fermented strains has been used. The health functional fermented wine emphasized is being produced.
항산화란 산화를 억제하여 노화를 막는다는 의미로, 체내의 활성산소(reactive oxygen species)가 정상 세포를 공격하여 노화나 각종 질병의 원인으로 작용한다. 따라서, 활성산소를 제거하는 것이 세포의 산화를 막는 방법이며, 활성산소를 해가 없는 물질로 바꿔주는 항산화 효소가 중요하다고 할 수 있다. 다만, 연령이 증가할수록 체내에서 만들어지는 항산화 효소의 활성산소 제거 능력이 급격히 떨어지기 때문에 식품을 통해 항산화 물질을 섭취하는 것이 좋다고 알려져있다. Antioxidant means to prevent aging by inhibiting oxidation, and reactive oxygen species in the body attack normal cells and act as a cause of aging and various diseases. Therefore, it can be said that removing free radicals is a way to prevent cell oxidation, and antioxidant enzymes that change free radicals into harmless substances are important. However, it is known that it is good to consume antioxidants through food because the ability of the antioxidant enzymes produced in the body to remove active oxygen rapidly decreases with age.
표피 가장 아래 기저층의 멜라닌 세포는 피부의 다양한 자극 요인에 의해 멜라닌을 만들어 위층으로 보내게 되는데, 이 멜라닌이 각질층에 도달하여 과색소 침착증을 유발하여 피부가 검게 보인다. 불필요한 멜라닌 색소를 재빨리 배출해서 그 사람이 지니고 있는 본래 피부의 투명함을 되찾는 일을 피부 미백이라 한다. 식품의약품안전청에 미백 성분으로 등록된 물질은 닥나무 추출물, 알부틴, 에틸아스코빌에텔, 유용성 감초 추출물, 아스코빌글루코사이드, 나이아신아마이드, 알파-비사볼올 및 아스코빌테트라이소팔미테이트 등이 있으며, 이와 같은 물질을 이용해 로션이나 액제, 크림, 마스크팩 등으로 만드는 것이 미백 화장품이다. Melanocytes in the basal layer, the lowest layer of the epidermis, make melanin by various stimulating factors of the skin and send it to the upper layer. Skin whitening is the process of quickly discharging unnecessary melanin and restoring the original skin's transparency. Substances registered as whitening ingredients by the Food and Drug Administration include mulberry extract, arbutin, ethyl ascorbyl ether, oil-soluble licorice extract, ascorbyl glucoside, niacinamide, alpha-bisabolol, and ascorbyl tetraisopalmitate, such substances Whitening cosmetics is to make lotions, liquids, creams, and mask packs using
한편, 와인과 같은 베리류의 알코올 발효는 다양한 미생물들의 작용에 의해 복잡한 화학 반응이 단계적으로 반복되면서 이루어진다. 많은 해외 국가에서는 사카로마이세스 세레비지애를 스타터(starter)로 사용하여 와인의 품질향상을 도모하고 있으며, 알코올 발효능이 우수하고 와인의 품질 향상에 도움이 되는 효모 선별에 많은 노력을 기울이고 있다.On the other hand, alcoholic fermentation of berries such as wine is made by repeating complex chemical reactions step by step by the action of various microorganisms. In many foreign countries, Saccharomyces cerevisiae is used as a starter to improve the quality of wine, and efforts are being made to select yeast that has excellent alcohol fermentation ability and helps improve the quality of wine. .
한편, 한국등록특허 제1743526호에서는 '국내 포도에서 분리된 내당성이 우수한 사카로마이세스 세레비지애 균주'가 개시되어 있고, 한국등록특허 제1703249호에서는 '신규 사카로마이세스 세레비지에 Y28 균주 및 이를 이용한 참다래-감 혼합 와인의 제조방법'이 개시되어 있으나, 본 발명의 '블루베리로부터 분리된 티로시나아제 저해 활성 및 항산화 활성이 있는 사카로마이세스 세레비지애 FT4-4 균주 및 이의 용도'에 대해서는 기재된 바가 없다.On the other hand, Korean Patent No. 1743526 discloses 'Saccharomyces cerevisiae strain with excellent sugar tolerance isolated from domestic grapes', and Korean Patent No. 1703249 discloses 'New Saccharomyces cerevisiae Y28 Saccharomyces cerevisiae FT4-4 strain having tyrosinase inhibitory activity and antioxidant activity isolated from blueberries and its 'Saccharomyces cerevisiae FT4-4 strain and its There is no mention of 'use'.
본 발명은 상기와 같은 요구에 의해 도출된 것으로서, 본 발명자들은 블루베리 및 블루베리 엑기스로부터 알코올, 당 및 아황산에 대한 내성이 있고, 알코올 생성능, β-글루코시다아제(glucosidase) 활성, 티로시나아제(tyrosinase) 저해 활성, 항산화 활성이 있고, 바이오제닉 아민인 히스타민 및 티라민, 유해효소인 우레아제를 생성하지 않으며, 피부생리활성 물질인 β-글루칸의 함량이 높은 사카로마이세스 세레비지애 FT4-4 균주(수탁번호: KCCM12522P)를 분리하였다. 본 발명의 사카로마이세스 세레비지애 FT4-4 균주는 와인 제조를 위한 스타터 균주 및 미백용 화장료 조성물에 사용이 가능함을 확인함으로써, 본 발명을 완성하였다.The present invention was derived from the above needs, and the present inventors have resistance to alcohol, sugar and sulfurous acid from blueberries and blueberry extracts, alcohol production ability, β-glucosidase activity, tyrosinase (tyrosinase) Saccharomyces cerevisiae FT4-4 has inhibitory and antioxidant activity, does not produce biogenic amines histamine and tyramine, and urease, a harmful enzyme, and has a high content of β-glucan, a skin bioactive substance A strain (Accession No.: KCCM12522P) was isolated. By confirming that the Saccharomyces cerevisiae FT4-4 strain of the present invention can be used in a starter strain for wine production and a cosmetic composition for whitening, the present invention has been completed.
상기 과제를 해결하기 위해, 본 발명은 알코올, 당 및 아황산에 대한 내성이 있고, 알코올 생성능, β-글루코시다아제(glucosidase) 활성, 티로시나아제(tyrosinase) 저해 활성, 항산화 활성이 있고, 바이오제닉 아민, 유해효소를 생성하지 않으며, 피부생리활성 물질을 생산하는, 기탁번호가 KCCM12522P인 사카로마이세스 세레비지애(Saccharomyces cerevisiae) FT4-4 균주를 제공한다. In order to solve the above problems, the present invention has resistance to alcohol, sugar and sulfurous acid, alcohol production ability, β-glucosidase activity, tyrosinase inhibitory activity, antioxidant activity, and biogenic It does not produce amines, harmful enzymes, and produces skin physiologically active substances, with an accession number of KCCM12522P Saccharomyces cerevisiae ) Provides a FT4-4 strain.
또한, 본 발명은 상기 균주, 이의 배양액, 상기 배양액의 농축액 또는 그의 건조물을 유효성분으로 포함하는 알코올 생산용 조성물을 제공한다.In addition, the present invention provides a composition for producing alcohol comprising the strain, its culture solution, the concentrate of the culture solution, or a dried product thereof as an active ingredient.
또한, 본 발명은 상기 균주, 이의 배양액, 상기 배양액의 농축액 또는 그의 건조물을 유효성분으로 포함하는 피부 미백용 화장료 조성물을 제공한다. In addition, the present invention provides a cosmetic composition for skin whitening comprising the strain, its culture medium, a concentrate of the culture medium, or a dried product thereof as an active ingredient.
또한, 본 발명은 상기 균주, 이의 배양액, 상기 배양액의 농축액 또는 그의 건조물을 유효성분으로 포함하는 발효식품 제조용 스타터(starter) 조성물을 제공한다. In addition, the present invention provides a starter composition for producing a fermented food comprising the strain, its culture medium, a concentrate of the culture medium, or a dried product thereof as an active ingredient.
본 발명의 사카로마이세스 세레비지애(Saccharomyces cerevisiae) FT4-4 균주는 알코올, 당 및 아황산에 대한 내성이 있고, 알코올 생성능, β-글루코시다아제(glucosidase) 활성, 티로시나아제(tyrosinase) 저해 활성, 항산화 활성이 있고, 바이오제닉 아민, 유해효소를 생성하지 않으며, 피부생리활성 물질 함량이 높으므로 와인 제조를 위한 스타터 균주 및 피부 미백용 화장료 조성물 등의 관련 산업 분야에 매우 유용하게 이용될 수 있다. Saccharomyces cerevisiae FT4-4 strain of the present invention has resistance to alcohol, sugar and sulfurous acid, alcohol production ability, β-glucosidase activity, tyrosinase inhibition It has active and antioxidant activity, does not produce biogenic amines and harmful enzymes, and has a high content of skin bioactive substances, so it can be very usefully used in related industrial fields such as starter strains for wine production and cosmetic compositions for skin whitening. there is.
도 1은 본 발명에서 분리한 사카로마이세스 세레비지애 FT4-4 균주의 계통도를 나타낸 것이다.
도 2는 본 발명에서 분리한 사카로마이세스 세레비지애 FT4-4 균주의 배양시간에 따른 건조 균체량, 생균수 및 흡광도를 측정한 결과이다. 3회 반복한 실험의 평균값을 나타내었다. △: 건조 균체량(g/L), ■: 생균수(log10 CFU/㎖), ●: 흡광도(660nm)
도 3은 본 발명에서 분리한 사카로마이세스 세레비지애 FT4-4 균주의 알코올(A), 당(B) 및 아황산(C) 내성에 대한 결과를 나타낸 결과이다. 3회 반복한 실험의 평균값을 나타내었다. 1 shows a phylogenetic diagram of the Saccharomyces cerevisiae FT4-4 strain isolated in the present invention.
2 is a result of measuring the dry cell mass, the number of viable cells and the absorbance according to the culture time of the Saccharomyces cerevisiae FT4-4 strain isolated in the present invention. The average value of the experiment repeated three times is shown. △: dry cell mass (g/L), ■: viable cell count (log 10 CFU/ml), ●: absorbance (660 nm)
3 is a result showing the alcohol (A), sugar (B) and sulfurous acid (C) resistance of the Saccharomyces cerevisiae FT4-4 strain isolated in the present invention. The average value of the experiment repeated three times is shown.
본 발명의 목적을 달성하기 위하여, 본 발명은 알코올, 당 및 아황산에 대한 내성이 있고, 알코올 생성능, β-글루코시다아제(glucosidase) 활성, 티로시나아제(tyrosinase) 저해 활성, 항산화 활성이 있고, 바이오제닉 아민, 유해효소를 생성하지 않으며, 피부생리활성 물질을 생산하는, 기탁번호가 KCCM12522P인 사카로마이세스 세레비지애(Saccharomyces cerevisiae) FT4-4 균주를 제공한다.In order to achieve the object of the present invention, the present invention has resistance to alcohol, sugar and sulfurous acid, alcohol production ability, β-glucosidase activity, tyrosinase inhibitory activity, antioxidant activity, It provides a biogenic amine, Saccharomyces cerevisiae FT4-4 strain that does not produce a biogenic amine, a harmful enzyme, and produces a skin bioactive substance, with an accession number of KCCM12522P.
본 발명에서는 전라북도 순창군에서 재배하여 수확한 블루베리 및 블루베리 엑기스로부터 알코올, 당 및 아황산에 대한 내성이 있고, 알코올 생성능, β-글루코시다아제(glucosidase) 활성, 티로시나아제(tyrosinase) 저해 활성, 항산화 활성이 있고, 바이오제닉 아민, 유해효소를 생성하지 않으며, 피부생리활성 물질을 생산하는 효모를 분리하였으며, 최종 선별된 균주의 18S rRNA 염기서열 분석을 통해 동정한 결과, 사카로마이세스 세레비지애(Saccharomyces cerevisiae) 균주임을 확인하였다. 본 발명자는 상기 최종 선별된 균주를 사카로마이세스 세레비지애(Saccharomyces cerevisiae) FT4-4 균주로 명명하고 한국미생물보존센터(KCCM)에 2019년 5월 3일자로 기탁하였다(수탁번호: KCCM12522P).In the present invention, there is resistance to alcohol, sugar and sulfurous acid from blueberries and blueberry extracts grown and harvested in Sunchang-gun, Jeollabuk-do, alcohol-producing ability, β-glucosidase activity, tyrosinase inhibitory activity, Yeast that has antioxidant activity, does not produce biogenic amines and harmful enzymes, and produces skin bioactive substances was isolated, and as a result of identification through 18S rRNA sequencing of the finally selected strain, Saccharomyces cerevisiae Jiae ( Saccharomyces cerevisiae ) It was confirmed that the strain. The present inventor named the final selected strain Saccharomyces cerevisiae FT4-4 strain and deposited it with the Korea Center for Microorganisms Conservation (KCCM) on May 3, 2019 (Accession No.: KCCM12522P) .
본 발명의 기탁번호가 KCCM12522P인 사카로마이세스 세레비지애 FT4-4 균주에 있어서, 상기 바이오제닉 아민은 히스타민(histamine) 및 티라민(tyramine)이고, 상기 유해효소는 우레아제(urease)이며, 상기 피부생리활성 물질은 β-글루칸(glucan)일 수 있으나, 이제 제한되지 않는다. 또한, 상기 알코올 내성은 8~10%의 무수에탄올에 대한 알코올 내성이며, 당 내성은 30~50%의 글루코스에 대한 당 내성이며, 아황산 내성은 100~300 ppm의 메타중아황산칼륨에 대한 아황산 내성이다. In the Saccharomyces cerevisiae FT4-4 strain whose deposit number is KCCM12522P of the present invention, the biogenic amine is histamine and tyramine, and the harmful enzyme is urease, and the skin The physiologically active substance may be β-glucan, but is not limited thereto. In addition, the alcohol resistance is alcohol resistance to 8-10% of absolute ethanol, sugar resistance is sugar resistance to 30-50% glucose, and sulfurous acid resistance is sulfurous acid resistance to 100-300 ppm potassium metabisulfite am.
본 발명은 또한, 상기 기탁번호가 KCCM12522P인 사카로마이세스 세레비지애(Saccharomyces cerevisiae) FT4-4 균주, 이의 배양액, 상기 배양액의 농축액 또는 그의 건조물을 유효성분으로 포함하는 알코올 생산용 조성물을 제공한다. The present invention also provides a composition for producing alcohol comprising, as an active ingredient, the Saccharomyces cerevisiae FT4-4 strain, the culture solution thereof, the concentrate of the culture solution, or the dried product thereof, the accession number of which is KCCM12522P. .
본 발명의 일 구현 예에 따른 조성물에서, 상기 알코올은 과실류를 발효시킨 알코올일 수 있으며, 가장 바람직하게는 베리류를 발효시킨 와인일 수 있으나, 이에 제한되지 않는다. In the composition according to an embodiment of the present invention, the alcohol may be alcohol obtained by fermenting fruits, and most preferably may be wine obtained by fermenting berries, but is not limited thereto.
본 발명의 균주를 배양하는 방법은 당업계에 통상적으로 이용되는 방법에 따라 배양할 수 있으며, 특별한 방법에 한정되는 것은 아니다. The method of culturing the strain of the present invention may be cultured according to a method commonly used in the art, and is not limited to a particular method.
본 발명의 균주를 배양하는 단계에서 얻어지는 상기 균주 또는 상기 균주의 배양물 또는 상기 균주의 배양액의 농축액을 첨가제로 사용할 경우, 상기 균주 또는 상기 균주의 배양물 또는 상기 균주의 배양액의 농축액을 그대로 첨가하거나 다른 첨가제를 함께 사용할 수 있으며, 통상적인 방법에 따라 적절하게 사용될 수 있다. 유효 성분의 혼합양은 그의 사용 목적에 따라 적합하게 결정될 수 있다.When using as an additive the concentrate of the strain or the culture of the strain or the culture solution of the strain obtained in the step of culturing the strain of the present invention, the concentrate of the strain or the culture of the strain or the culture solution of the strain is added as it is or Other additives may be used together, and may be appropriately used according to a conventional method. The mixing amount of the active ingredient may be appropriately determined depending on the intended use thereof.
본 발명은 또한, 상기 기탁번호가 KCCM12522P인 사카로마이세스 세레비지애(Saccharomyces cerevisiae) FT4-4 균주, 이의 배양액, 상기 배양액의 농축액 또는 그의 건조물을 유효성분으로 포함하는 피부 미백용 화장료 조성물을 제공한다.The present invention also provides a cosmetic composition for skin whitening comprising, as an active ingredient, the Saccharomyces cerevisiae FT4-4 strain whose accession number is KCCM12522P, a culture solution thereof, a concentrate of the culture solution, or a dried product thereof as an active ingredient do.
본 발명에 따른 화장료 조성물은, 티로시나제(tyrosinase) 저해 활성을 가지는 기탁번호가 KCCM12522P인 사카로마이세스 세레비지애(Saccharomyces cerevisiae) FT4-4 균주, 이의 배양액, 상기 배양액의 농축액 또는 그의 건조물을 유효성분으로 포함하며, 피부 미백용으로 사용 가능하다. The cosmetic composition according to the present invention contains a Saccharomyces cerevisiae FT4-4 strain having an accession number of KCCM12522P having tyrosinase inhibitory activity, a culture solution thereof, a concentrate of the culture solution or a dried product thereof as an active ingredient and can be used for skin whitening.
본 발명의 일 구현예에 따른 화장료 조성물에 있어서, 상기 피부 미백용 화장료 조성물은 크림, 유연화장수, 영양화장수, 팩, 에센스, 헤어토닉, 샴푸, 린스, 헤어 컨디셔너, 헤어 트리트먼트, 젤, 스킨로션, 스킨소프너, 스킨토너, 아스트린젠트, 밀크로션, 모이스처 로션, 영양로션, 마사지 크림, 영양크림, 모이스처 크림, 핸드 크림, 파운데이션, 영양에센스, 선스크린, 비누, 클렌징폼, 클렌징로션, 클렌징크림, 바디 로션 및 바디 클렌저로 이루어지는 군으로부터 선택된 어느 하나의 제형을 가질 수 있으나, 이에 제한되지 않는다. 이들 각 제형으로 이루어진 화장료 조성물은 그 제형의 제제화에 필요하고 적절한 각종의 기제와 첨가물을 함유할 수 있으며, 이들 성분의 종류와 양은 당업자에 의해 용이하게 선정될 수 있다.In the cosmetic composition according to an embodiment of the present invention, the cosmetic composition for skin whitening is a cream, softening lotion, nutrient lotion, pack, essence, hair tonic, shampoo, conditioner, hair conditioner, hair treatment, gel, skin lotion , Skin Softener, Skin Toner, Astringent, Milk Lotion, Moisture Lotion, Nourishing Lotion, Massage Cream, Nourishing Cream, Moisture Cream, Hand Cream, Foundation, Nourishing Essence, Sunscreen, Soap, Cleansing Foam, Cleansing Lotion, Cleansing Cream, Body It may have any one formulation selected from the group consisting of lotions and body cleansers, but is not limited thereto. The cosmetic composition composed of each of these formulations may contain various bases and additives necessary and appropriate for the formulation of the formulation, and the types and amounts of these components can be easily selected by those skilled in the art.
본 발명의 화장료 조성물은 형광물질, 살진균제, 굴수성 유발물질, 보습제, 방향제, 방향제 담체, 단백질, 용해화제, 당 유도체, 일광차단제, 비타민, 식물 추출물 등을 포함하는 부형제를 추가로 함유할 수 있다.The cosmetic composition of the present invention may further contain excipients including fluorescent substances, fungicides, hydrophobicity inducers, moisturizers, fragrances, fragrance carriers, proteins, solubilizers, sugar derivatives, sunscreens, vitamins, plant extracts, and the like. .
본 발명은 또한, 상기 기탁번호가 KCCM12522P인 사카로마이세스 세레비지애(Saccharomyces cerevisiae) FT4-4 균주, 이의 배양액, 상기 배양액의 농축액 또는 그의 건조물을 유효성분으로 포함하는 발효식품 제조용 스타터(starter) 조성물을 제공한다. The present invention also provides a Saccharomyces cerevisiae FT4-4 strain whose accession number is KCCM12522P, a culture solution thereof, a concentrate of the culture solution or a dry product thereof as an active ingredient. Starter for manufacturing fermented food A composition is provided.
본 발명에 있어서, 발효식품 제조용 스타터(starter)란 발효식품 제조를 위해 발효에 관여하는 미생물을 포함하는 제제 또는 조성물을 의미한다. 발효식품 제조 시에 첨가함으로써 발효된 식품에서 생장할 수 있는 미생물 또는 우점종으로 생장할 수 있는 미생물을 제공하기 위하여 사용된다. 상기 식품 발효용 스타터를 사용하여 식품을 제조하는 경우, 상기 식품 발효용 스타터에 포함된 미생물에 의하여, 식품의 품질을 일정하게 조절하거나, 특정한 목적, 일 예로 식품에서 이취를 발생시키지 않거나, 감소시키는 목적을 달성할 수 있다. 본 발명에서는 사카로마이세스 세레비지애 FT4-4 균주 또는 이의 배양액을 스타터 균주로 이용함으로써, 알코올, 당 및 아황산에 대한 내성이 있고, 알코올 생성능, β-글루코시다아제(glucosidase) 활성, 티로시나아제(tyrosinase) 저해 활성, 항산화 활성이 있고, 바이오제닉 아민, 유해효소를 생성하지 않으며, 피부생리활성 물질 함량이 높은 발효 식품을 제조할 수 있다. In the present invention, a starter for fermented food production means a preparation or composition containing microorganisms involved in fermentation for the production of fermented food. It is used to provide microorganisms that can grow in fermented foods or microorganisms that can grow as dominant species by adding them during the manufacture of fermented foods. In the case of manufacturing food using the starter for food fermentation, by the microorganisms included in the starter for food fermentation, the quality of food is constantly controlled, or for a specific purpose, for example, no off-flavor is generated in food or reduced. purpose can be achieved. In the present invention, by using the Saccharomyces cerevisiae FT4-4 strain or its culture medium as a starter strain, there is resistance to alcohol, sugar and sulfurous acid, alcohol production ability, β-glucosidase activity, tyrosina It has tyrosinase inhibitory activity and antioxidant activity, does not produce biogenic amines and harmful enzymes, and can produce fermented food with a high content of skin bioactive substances.
본 발명의 일 구현 예에 따른 발효식품 제조용 스타터 조성물에서, 상기 발효식품은 과실류를 발효시킨 발효주일 수 있고, 바람직하게는 베리류를 발효시킨 와인일 수 있으나, 이에 제한되지 않는다.In the starter composition for manufacturing fermented food according to an embodiment of the present invention, the fermented food may be a fermented wine obtained by fermenting fruits, preferably wine obtained by fermenting berries, but is not limited thereto.
이하, 본 발명을 실시예에 의해 상세히 설명한다. 단, 하기 실시예는 본 발명을 예시하는 것일 뿐, 본 발명의 내용이 이에 한정되는 것은 아니다. Hereinafter, the present invention will be described in detail by way of Examples. However, the following examples are merely illustrative of the present invention, and the content of the present invention is not limited thereto.
재료 및 방법Materials and Methods
1. 균주 분리 및 배양 조건1. Strain isolation and culture conditions
전라북도 순창군에서 재배하여 수확한 블루베리 및 블루베리 엑기스를 구입하여 실험에 사용하였다. 증균을 위하여 250 ㎖의 YPD(1% 효모추출물, 2% 펩톤, 2% 덱스트로오스) 액체배지에 블루베리 및 블루베리 엑기스를 넣고 30℃에서 48시간 발효하여 균주 분리에 이용하였다. 10 g의 블루베리 및 블루베리 엑기스, 증균시킨 블루베리 및 블루베리 엑기스를 균질화하여 90 ㎖의 멸균 생리식염수(0.85% NaCl)에 넣어 십진법으로 희석한 후 박테리아 생장을 억제하기 위해 100 ㎍/㎖의 클로람페니콜(chloramphenicol)을 함유한 YPD 고체배지에 도말하여 30℃에서 2일 동안 배양하였다. 그 중에서 알코올을 생성하는 균주를 선별하였고, 20%의 글리세롤을 포함한 YPD 액체배지에 혼합하여 4℃에서 보관하였다. 이후, YPD 액체배지에서 30℃에서 2일 동안 배양하여 활성화시킨 다음 실험에 사용하였다. Blueberries and blueberry extracts grown and harvested in Sunchang-gun, Jeollabuk-do were purchased and used in the experiment. For enrichment, blueberries and blueberry extracts were added to 250 ml of YPD (1% yeast extract, 2% peptone, 2% dextrose) liquid medium, and fermented at 30° C. for 48 hours, which was used to isolate strains. 10 g of blueberries and blueberry extract, enriched blueberries and blueberry extracts are homogenized, put in 90 ml of sterile saline (0.85% NaCl), diluted in decimal, and then 100 μg/ml of It was smeared on YPD solid medium containing chloramphenicol and incubated at 30°C for 2 days. Among them, strains producing alcohol were selected, mixed in YPD liquid medium containing 20% glycerol, and stored at 4°C. Thereafter, it was activated by culturing at 30° C. for 2 days in YPD liquid medium, and then used for the experiment.
2. 알코올 생성 균주의 선별2. Selection of alcohol-producing strains
알코올 생성능이 우수한 균주의 1차 선별을 위해 듀람 튜브 테스트(durham tube test)를 통해 가스 생성능을 확인하였다. 선별된 균주의 배양을 위해 YPD 액체배지에서 30℃에서 24시간 교반하여 배양하였고, 배양액의 2%를 24% 글루코스가 함유된 10 ㎖의 YPD 액체배지에 접종하여, 교반없이 30℃에서 48시간 정치 배양하였다. 그 후, 가스 생성여부를 확인하여 알코올 생성 균주를 1차 선별하였고, 1차로 선별된 균주는 24% 글루코스가 함유된 YPD 액체배지에 접종하여 48시간 배양 후, 배양액을 원심분리하여 상등액을 취해 0.45 ㎛ 시린지 필터를 이용하여 여과한 뒤, 표 1에 따른 조건에 따라 HPLC 분석을 통해 알코올 생성능이 우수한 균주를 2차 선별하였다. For the primary screening of strains with excellent alcohol-producing ability, the gas-producing ability was confirmed through the Durham tube test. For culturing of the selected strain, it was cultured with stirring at 30° C. for 24 hours in YPD medium, and 2% of the culture medium was inoculated into 10 ml of YPD medium containing 24% glucose, and left at 30° C. for 48 hours without stirring. cultured. After that, the alcohol-producing strains were first selected by checking whether gas was produced, and the first selected strains were inoculated in a YPD liquid medium containing 24% glucose and cultured for 48 hours, then the culture solution was centrifuged and the supernatant was taken 0.45 After filtration using a ㎛ syringe filter, strains with excellent alcohol production ability were secondarily selected through HPLC analysis according to the conditions according to Table 1.
3. 바이오제닉 아민 분석3. Biogenic amine analysis
선별된 균주의 바이오제닉 아민 생성 여부 조사는 YPD 액체배지에 각 균주를 접종하고, 150 rpm의 진탕배양기에서 30℃, 24시간 전배양 후, 배양액 1 ㎖을 티라민 및 히스타민의 전구체 아미노산인 티로신 및 히스티딘이 0.1% 포함된 YPD 액체배지 9 ㎖에 접종하고 150 rpm의 진탕배양기에서 30℃, 48시간 본배양하였다. 본 배양액은 13,000 rpm에서 30분 동안 원심분리하여 균체를 제거하고, 균체가 제거된 상등액을 바이오제닉 아민 분석을 위한 시료로 사용하였다. 시료 용액과 표준 용액을 각각 0.5 ㎖씩 취한 후, 1,7-diaminoheptane(sigma, USA) 0.25 ㎖과 포화탄산나트륨용액 0.25 ㎖, 1% 아세톤, 댄실염화물 0.4 ㎖을 혼합한 후 45℃에서 1시간 동안 유도체화 하였다. 유도체화 한 시료에 0.25 ㎖의 10% 프롤린을 가한 후 잔량의 댄실염화물을 제거한 뒤 2.5 ㎖의 에테르를 가하여 3분간 진탕한 후, 분리된 상등액을 취하여 증발시키고 남은 잔사를 아세토나이트릴 0.5 ㎖에 녹이고 0.45 ㎛ 필터로 여과한 후 HPLC 분석하였다. 분석조건은 아래 표 2와 같다. To investigate the biogenic amine generation of the selected strains, each strain is inoculated in a YPD liquid medium, and after pre-culturing at 30° C. for 24 hours in a shaking incubator at 150 rpm, 1 ml of the culture medium is tyrosine and histidine, which are precursor amino acids of tyramine and histamine. It was inoculated into 9 ml of this 0.1% YPD liquid medium and incubated for 48 hours at 30° C. in a shaking incubator at 150 rpm. The culture solution was centrifuged at 13,000 rpm for 30 minutes to remove cells, and the supernatant from which the cells were removed was used as a sample for biogenic amine analysis. After taking 0.5 ml of each of the sample solution and the standard solution, 0.25 ml of 1,7-diaminoheptane (sigma, USA), 0.25 ml of saturated sodium carbonate solution, 1% acetone, and 0.4 ml of Dansyl chloride were mixed, followed by mixing at 45°C for 1 hour. derivatized. After adding 0.25 ml of 10% proline to the derivatized sample, removing the remaining amount of dansyl chloride, adding 2.5 ml of ether, shaking for 3 minutes, taking the separated supernatant, evaporating, and dissolving the remaining residue in 0.5 ml of acetonitrile After filtration through a 0.45 μm filter, HPLC analysis was performed. The analysis conditions are shown in Table 2 below.
B: 0.1% formic acid in ACNA: 0.1% formic acid in H2O
B: 0.1% formic acid in ACN
A : B = 35 : 65, 10~15min
A : B = 20 : 80, 15~20 min
A : B = 10 : 90, 20~30 min
A : B = 10 : 90, 40 min overA : B = 45 : 55, 0~10 min
A : B = 35 : 65, 10~15min
A : B = 20 : 80, 15~20 min
A : B = 10 : 90, 20~30 min
A : B = 10 : 90, 40 min over
4. 유해효소 생성 분석4. Hazardous Enzyme Production Analysis
선별 균주의 유해효소 생성 여부는 Urea rapid test kit(MB cell, Korea)를 이용하여 확인하였다. 상기 키트에 선별 균주를 접종하고 바셀린 오일(vaseline oil)을 첨가하여 산소가 차단된 상태로 37℃에서 24시간 배양하였고 4시간 간격으로 색변화를 관찰하여 우레아제(urease) 생성 여부를 확인하였다. The generation of harmful enzymes in the selected strain was confirmed using the Urea rapid test kit (MB cell, Korea). Selected strains were inoculated into the kit, and vaseline oil was added, followed by incubation at 37° C. for 24 hours in a state in which oxygen was blocked, and color change was observed at 4 hour intervals to determine whether urease was generated.
5. β-글루코시다아제 효소 활성 분석5. β-Glucosidase Enzyme Activity Assay
β-글루코시다아제(glucosidase) 효소의 활성을 분석하기 위해 1.0% 에스쿨린(esculin)과 0.5% 구연산철암모늄(ferric ammonium citrate)을 첨가하여 제조한 락토바실러스 MRS 아가(agar) 배지에 선별 균주를 접종하여 37℃에서 24시간 배양한 후 콜로니 주변에 생기는 검정색 투명환의 유무에 따라 β-글루코시다아제 효소의 활성을 측정하였다. To analyze the activity of the β-glucosidase enzyme, the selected strain was placed on a Lactobacillus MRS agar medium prepared by adding 1.0% esculin and 0.5% ferric ammonium citrate. After inoculation and incubation at 37° C. for 24 hours, the activity of the β-glucosidase enzyme was measured according to the presence or absence of a black transparent ring formed around the colony.
6. 티로시나아제 저해 활성 측정6. Measurement of tyrosinase inhibitory activity
선별된 균주의 티로시나아제(tyrosinase) 저해 활성을 측정하기 위해 YPD 액체배지에 접종하여 30℃에서 150 rpm으로 48시간 배양하였다. 배양액을 13,000 rpm으로 10분 동안 원심분리하여 균체를 회수하였다. 균체를 50 mM PBS 버퍼(pH 6.8)로 현탁하였다. 초음파분쇄기를 이용해 60℃에서 1시간 동안 균체를 파쇄 후 13,000 rpm에서 10분간 원심분리하여 상등액을 사용하였다. 기질은 1 mM L-tyrosine 용액을 50 mM PBS 버퍼(pH 6.8)에 완전히 녹여서 이용하였다. 시료 50 ㎕에 L-tyrosine 용액 100 ㎕를 혼합하고 티로시나아제(50 U/㎖) 50 ㎕를 첨가하여 37℃에서 30분간 반응시킨 후, 470 nm에서 흡광도를 측정하여 아래의 계산식으로 티로시나아제 저해 활성값을 계산하였다. In order to measure the tyrosinase inhibitory activity of the selected strain, it was inoculated into YPD broth and incubated at 30° C. at 150 rpm for 48 hours. The culture medium was centrifuged at 13,000 rpm for 10 minutes to recover the cells. The cells were suspended in 50 mM PBS buffer (pH 6.8). After disrupting the cells at 60° C. for 1 hour using an ultrasonic crusher, the supernatant was used by centrifugation at 13,000 rpm for 10 minutes. The substrate was used by completely dissolving 1 mM L-tyrosine solution in 50 mM PBS buffer (pH 6.8). 100 μl of L-tyrosine solution was mixed with 50 μl of sample, 50 μl of tyrosinase (50 U/ml) was added, and reacted at 37° C. for 30 minutes, absorbance was measured at 470 nm and tyrosinase was calculated using the following formula. Inhibitory activity values were calculated.
티로시나아제 저해 활성(%)=[1-(A/B)x100]Tyrosinase inhibitory activity (%)=[1-(A/B)x100]
A : 470 nm에서 시료 첨가된 티로시나아제 용액의 흡광도A: Absorbance of sample-added tyrosinase solution at 470 nm
B : 470 nm에서 시료 무첨가 티로시나아제 용액의 흡광도B: Absorbance of sample-free tyrosinase solution at 470 nm
7. 항산화 활성 분석7. Antioxidant Activity Assay
선별된 균주의 항산화 활성 분석을 위해 YPD 액체배지에서 30℃, 150 rpm으로 48시간 진탕배양 후 4℃, 13,000 rpm으로 10분간 원심분리하여 상등액을 시료로 이용하였다. DPPH(2,2-diphenyl-1-picryl-hydrazyl)를 이용한 자유 라디칼(free radical) 소거능은 시료 20 ㎕에 100 μM DPPH 에탄올 용액 180 ㎕를 혼합한 후 암실에서 30분간 반응시켜 UV/VIS 스펙트로미터로 517 nm에서 흡광도를 측정한 후 아래 식에 대입하여 산출하였으며, 대조군으로는 YPD 액체배지를 사용하였다. For the analysis of the antioxidant activity of the selected strains, the supernatant was used as a sample by incubating in YPD liquid medium at 30° C., 150 rpm for 48 hours with shaking, followed by centrifugation at 4° C., 13,000 rpm for 10 minutes. Free radical scavenging ability using DPPH (2,2-diphenyl-1-picryl-hydrazyl) was measured by mixing 180 μl of 100 μM DPPH ethanol solution with 20 μl of sample and reacting in the dark for 30 minutes with UV/VIS spectrometer. After measuring the absorbance at 517 nm, it was calculated by substituting the formula below, and YPD liquid medium was used as a control.
DPPH 자유 라디칼 소거 활성(%)=[1-(A/B)x100]DPPH free radical scavenging activity (%)=[1-(A/B)x100]
A : 517 nm에서 시료 첨가된 DPPH 용액의 흡광도A: Absorbance of sample-added DPPH solution at 517 nm
B : 517 nm에서 시료 무첨가 DPPH 용액의 흡광도B: Absorbance of sample-free DPPH solution at 517 nm
8. 선별 균주의 동정 및 계통도 작성8. Identification and phylogenetic of selected strains
최종 선별된 균주를 동정하기 위해 균체에서 DNA를 추출하여 ITS1(5'-TCCGTAGGTGAACCTGCGG-3':서열번호 2)과 ITS4 프라이머(5'-TCCTCCCGCTTATTGATATGC-3':서열번호 3)를 사용하여 18S rRNA 유전자를 증폭하였고, 증폭된 산물은 코스모진텍(Cosmogene tech.)에 의뢰하여 동정을 실시하였다. 염기서열은 ExTaxone-e 서버(http://www.eztaxon.org)를 통해 표준 균주의 염기서열을 확보하여 MEGA 6.0 program을 사용하여 염기서열 비교 후 계통도를 작성하였다. 계통도는 Neighbor-joining 알고리즘을 사용하여 분석하였고, 1,000회 반복으로 bootstrapping하여 계통도의 견고성을 확인하였다. 18S rRNA gene using ITS1 (5'-TCCGTAGGTGAACCTGCGG-3': SEQ ID NO: 2) and ITS4 primer (5'-TCCTCCCGCTTATTGATATGC-3': SEQ ID NO: 3) by extracting DNA from the cells to identify the finally selected strain was amplified, and the amplified product was identified by requesting Cosmogene tech. For the base sequence, the base sequence of the standard strain was obtained through the ExTaxone-e server (http://www.eztaxon.org), and the nucleotide sequence was compared using the MEGA 6.0 program and then a phylogenetic diagram was prepared. The phylogenetic tree was analyzed using the neighbor-joining algorithm, and the robustness of the phylogenetic tree was confirmed by bootstrapping with 1,000 repetitions.
9. β-글루칸 함량 분석9. β-glucan content analysis
선별된 균주의 β-글루칸(β-glucan) 함량을 조사하기 위해서 YPD 액체배지에서 150 rpm으로 48시간 동안 진탕배양하였고, 3,000 rpm으로 원심분리하여 분리된 균체를 증류수로 3회 세척하고 동결건조한 시료를 분석에 이용하였다. β-글루칸 함량 조사는 Yeast β-glucan kit(K-YBGL, Megazyme International Ireland Ltd.)를 이용하여 측정하였다. In order to investigate the β-glucan content of the selected strain, the cells were cultured with shaking at 150 rpm for 48 hours in YPD liquid medium, and the cells separated by centrifugation at 3,000 rpm were washed 3 times with distilled water and lyophilized. was used for the analysis. The β-glucan content was investigated using a Yeast β-glucan kit (K-YBGL, Megazyme International Ireland Ltd.).
10. 균체 성장 분석10. Cell Growth Analysis
선별된 균주의 시간에 따른 균체 성장을 분석하기 위하여 액체배지에 선별 균주를 접종하여 30℃, 150 rpm의 진탕배양기에서 2일 동안 전배양을 실시하였다. 균체 성장 조사를 위한 배지는 2% 글루코스가 함유된 YPD 액체배지를 사용하였으며, 각 액체배지에 전배양액 2%를 접종한 후 30℃에서 200 rpm으로 36시간 동안 배양하였다. 4시간 단위로 시료를 취하여 건조 균체량, 생균수, 흡광도를 측정하였다. 건조 균체량의 측정을 위하여 10 ㎖의 배양액을 13,000 rpm에서 20분간 원심분리하였다. 분리된 균체를 증류수로 3회 세척하고 80℃에서 항량이 될 때까지 건조시킨 후 무게를 측정하였다. 또한, 배양액 1 ㎖을 회수하여 단계희석하여 YPD 고체배지에 도말하여 30℃에서 48시간 배양한 후 생균수를 측정하였다. 건조 균체량과의 비교를 위한 흡광도 측정은 배양액 1 ㎖을 회수하여 13,000 rpm에서 20분간 원심분리한 후, 증류수에 3회 세척하고 멸균 증류수 1 ㎖에 재부유하여 660 nm에서 자외선/가시광선 분광광도계(UV/VIS spectrophotometer, SPECORD 200, Analytik Jena, Jena, Germany)를 사용하여 흡광도를 측정하고 기록하였다. In order to analyze the growth of the selected strains according to time, the selected strains were inoculated into the liquid medium and pre-cultured for 2 days in a shaking incubator at 30°C and 150 rpm. As a medium for cell growth investigation, a YPD liquid medium containing 2% glucose was used, and 2% of the pre-culture solution was inoculated into each liquid medium, and then cultured at 30° C. at 200 rpm for 36 hours. Samples were taken every 4 hours, and the dry cell mass, viable cell count, and absorbance were measured. To measure the dry cell mass, 10 ml of the culture solution was centrifuged at 13,000 rpm for 20 minutes. The separated cells were washed three times with distilled water, dried at 80° C. until constant weight, and then the weight was measured. In addition, 1 ml of the culture medium was recovered, diluted stepwise, spread on YPD solid medium, and cultured at 30° C. for 48 hours, and then the number of viable cells was measured. For absorbance measurement for comparison with the dry cell mass, 1 ml of the culture medium was recovered, centrifuged at 13,000 rpm for 20 minutes, washed three times in distilled water, resuspended in 1 ml of sterile distilled water, and then resuspended in 1 ml of sterile distilled water using an ultraviolet/visible light spectrophotometer ( Absorbance was measured and recorded using a UV/VIS spectrophotometer,
11. 알코올 내성, 당 내성, 아황산 내성 분석11. Analysis of alcohol tolerance, sugar tolerance, and sulfurous acid tolerance
선별된 균주의 알코올 내성은 균주를 YPD 액체배지에 접종한 후, 0, 8, 14 및 20%의 무수에탄올을 바로 첨가하고 30℃에서 72시간 동안 배양한 후 건조 균체량을 측정하여 분석하였다. 당 내성은 3, 30, 40 및 50%의 글루코스가 함유된 YPD 액체배지에 30℃에서 48시간 동안 균주를 배양한 후 건조 균체량을 측정하여 분석하였다. 아황산 내성은 100, 200 및 300 ppm의 메타중아황산칼륨이 함유된 YPD 액체배지에 30℃에서 48시간 동안 배양한 후 건조 균체량을 측정하여 분석하였다. Alcohol resistance of the selected strain was analyzed by inoculating the strain in YPD broth, immediately adding 0, 8, 14, and 20% absolute ethanol, and incubating at 30° C. for 72 hours by measuring the dry cell mass. Glucose tolerance was analyzed by measuring the dry cell mass after incubating the strain in YPD broth containing 3, 30, 40 and 50% glucose at 30° C. for 48 hours. Sulfurous acid resistance was analyzed by measuring the amount of dried cells after incubation for 48 hours at 30° C. in YPD liquid medium containing 100, 200 and 300 ppm potassium metabisulfite.
실시예 1. 알코올 생성 균주의 선별Example 1. Selection of alcohol-producing strains
블루베리 및 블루베리 엑기스로부터 약 150여 종의 균주를 선별하였고, 이를 대상으로 듀람 튜브 테스트(durham tube test)를 수행하여 가스 생성능이 우수한 53종의 균주를 1차 선별하였다. 하지만 가스 생성능은 낮지만, 알코올 생성능이 높은 균주도 있기 때문에, 추가로 HPLC 분석을 통하여 알코올 생성 여부를 확인한 결과, 총 60종의 균주가 선별되었고 이 중에서 5% 이상의 알코올 생성능을 가지는 5종의 균주를 최종 선별하였다(표 3). About 150 strains were selected from blueberries and blueberry extracts, and a durham tube test was performed on them to first select 53 strains with excellent gas-generating ability. However, since there are strains with low gas-producing ability but high alcohol-producing ability, additionally, as a result of confirming whether or not alcohol is produced through HPLC analysis, a total of 60 strains were selected. was finally selected (Table 3).
실시예 2. 바이오제닉 아민 분석Example 2. Biogenic amine analysis
바이오제닉 아민은 와인이나 발효식품 등에 존재하고 있으며, 알코올 발효 동안 다양한 효모 및 유산균에 의해 생성되고, 과량의 바이오제닉 아민을 섭취할 경우 매스꺼움, 구토, 고혈압, 두통과 같은 증상을 유발하는 것으로 알려져있어, 상기 5종의 선별 균주를 대상으로 바이오제닉 아민인 히스타민(histamine)과 티라민(tyramine)의 생성 여부를 조사하였다. 대조군으로는 균주를 접종하지 않은 YPD 액체배지를 사용하였다. 그 결과는 표 4와 같으며, 5종의 선별 균주 중 바이오제닉 아민 2종 모두를 생성하지 않는 균주는 FT4-4로 확인되었고, 대부분의 균주에서는 2종의 바이오제닉 아민이 검출되었지만 정량이 되지 않는 미미한 수치를 나타내었다. 따라서 상기 알코올 생성능과 바이오제닉 아민 생성 여부 결과를 통해 산업용 균주로 가장 적합한 효모는 FT4-4인 것을 확인하였다. Biogenic amines exist in wine and fermented foods, and are produced by various yeasts and lactic acid bacteria during alcoholic fermentation. Ingestion of excess biogenic amines is known to cause symptoms such as nausea, vomiting, high blood pressure, and headache. , was examined whether the biogenic amines histamine and tyramine were produced in the five selected strains. As a control, a YPD liquid medium that was not inoculated with the strain was used. The results are shown in Table 4, and the strain that does not produce both biogenic amines among the five selected strains was identified as FT4-4, and in most strains, two types of biogenic amines were detected but not quantified. showed insignificant values. Therefore, it was confirmed that the most suitable yeast as an industrial strain was FT4-4 through the alcohol production ability and biogenic amine production results.
결과는 3번 측정하였으며 표준편차로 표기하였음.Results were measured three times and expressed as standard deviation.
a N.D. - 검출되지 않음 a ND - not detected
b N.Q. - 정량되지 않음 b NQ - not quantified
실시예 3. 유해효소 생성 분석Example 3. Harmful enzyme production analysis
세포손상을 주는 기전으로 헬리코박터 파일로리(Helicobacter pylori) 감염 시 우레아제(Urease)에 의해 생성되는 암모니아에 의해 세포에 손상이 생기고, 세포공포독소에 의해 상피세포의 공포화가 발생하며, 호중구에서 분비된 염증매개물질과 활성 산소화물에 의해서도 세포가 손상된다. 상피세포의 손상은 세포의 위축성 변화를 일으키고, 보상 기전으로 인해 활발하게 증식하게 된 세포는 발암물질에 의하여 유전자가 손상받을 기회가 많아지므로, 선별 균주에 대한 세포의 유해효소인 우레아제 생성을 분석하였고, 그 결과 FT4-4, FT4-7 및 FT4-140 균주에서 우레아제가 생성되지 않음을 확인하였다(표 5).As a mechanism of cellular damage, Helicobacter pylori infection causes cell damage by ammonia produced by urease, vacuolization of epithelial cells by cytostatic toxin, and mediator of inflammation secreted by neutrophils Cells are also damaged by substances and reactive oxygen species. Damage to epithelial cells causes atrophic changes in cells, and cells that have actively proliferated due to a compensatory mechanism have a greater chance of being damaged by carcinogens. , As a result, it was confirmed that urease was not produced in the FT4-4, FT4-7 and FT4-140 strains (Table 5).
실시에 4. β-글루코시다아제 효소 활성 분석Example 4. β-Glucosidase Enzyme Activity Assay
β-글루코시다아제(β-glucosidase)를 생산하는 미생물로 곰팡이, 효모, 토양세균 및 초고온성 고세균 등 다양한 계통군에 속하는 균주들이 알려져있고, 이들이 생산하는 β-글루코시다아제에 대한 효소학적 특성과 유전자도 다수 알려져있다. 또한, β-글루코시다아제는 전통발효식품에 주로 존재하는 대두 이소플라본 배당체인 제니스틴과 다이드진의 체내 흡수를 위해 비배당체 형태로 전환시키는 촉매작용에 관여한다고 알려져있다. 이에 본 발명자는 선별 균주에 대한 β-글루코시다아제 효소 활성을 분석하였고 그 결과, 4종의 효모에서 활성이 있는 것으로 확인하였으며, FT4-4 균주의 β-글루코시다아제의 활성이 가장 우수한 것으로 확인되었다(표 6). As microorganisms that produce β-glucosidase, strains belonging to various phylogenetic groups such as mold, yeast, soil bacteria and hyperthermia archaea are known. Many genes are also known. In addition, β-glucosidase is known to be involved in the catalytic action of converting soybean isoflavone glycosides genistin and daidgin, which are mainly present in traditional fermented foods, into non-glycosides for body absorption. Accordingly, the present inventors analyzed the enzyme activity of β-glucosidase against the selected strain, and as a result, it was confirmed that there was activity in 4 types of yeast, and it was confirmed that the activity of β-glucosidase of the FT4-4 strain was the best. became (Table 6).
-; 검출되지 않음, +; 1.0~1.4 cm, ++; 1.5~1.9 cm, +++; 2.0 cm 이상-; not detected, +; 1.0-1.4 cm, ++; 1.5-1.9 cm, +++; 2.0 cm or more
실시예 5. 티로시나아제 저해 활성 측정Example 5. Measurement of tyrosinase inhibitory activity
피부 세포에서 멜라닌은 티로시나아제(tyrosinase)의 활성에 의해 합성되며, L-tyrosine을 L-dihydroxy phenylalanine(L-DOPA)으로 전환시키고, L-DOPA을 다시 DOPA quinone으로 변환하여 최종적으로 멜라닌을 생성한다. 이렇게 생성된 멜라닌에 의해 세포 내 색소 침착을 유발하여 기미 및 주근깨를 형성하므로 멜라닌 합성 효소의 발현을 저해시켜야 한다. 이에 본 발명자는 선별 균주에 대한 티로시나아제 저해 활성을 측정한 결과, FT4-4 균주가 가장 높은 활성을 보이는 것을 확인하였다(표 7). In skin cells, melanin is synthesized by the activity of tyrosinase, L-tyrosine is converted to L-dihydroxy phenylalanine (L-DOPA), and L-DOPA is converted back to DOPA quinone to finally produce melanin. do. The melanin produced in this way induces intracellular pigmentation to form spots and freckles, so the expression of melanin synthetase must be inhibited. Accordingly, the present inventors measured the tyrosinase inhibitory activity against the selected strain, and confirmed that the FT4-4 strain showed the highest activity (Table 7).
실시예 6. 항산화 활성 측정Example 6. Measurement of antioxidant activity
체내 다양한 반응에 의해 생성되는 활성산소는 생체 효소 및 단백질의 산화적 손상을 일으켜 유전자의 손상과 암 등을 유발한다. 하지만 일부 미생물을 이용한 효소적 또는 비효소적 방법을 통해 활성산소를 소거시키면 항산화 활성이 증진되어 노화를 억제할 수 있다고 알려져있다. 이에 본 발명자는 선별 균주에 대한 DPPH 활성을 측정한 결과, 모든 선별 균주가 30% 이상의 항산화 활성을 보였으며 특히, FT4-4가 가장 높은 항산화 활성을 지닌 균주로 확인하였다(표 8). Free radicals generated by various reactions in the body cause oxidative damage to biological enzymes and proteins, causing gene damage and cancer. However, it is known that by removing free radicals through enzymatic or non-enzymatic methods using some microorganisms, antioxidant activity is enhanced and aging can be inhibited. Accordingly, the present inventors measured the DPPH activity against the selected strains, and as a result, all of the selected strains showed an antioxidant activity of 30% or more, and in particular, FT4-4 was confirmed as the strain with the highest antioxidant activity (Table 8).
실시예 7. 선별 균주의 동정 및 계통도 작성Example 7. Identification and phylogenetic of selected strains
상기 실시예를 통해 가장 우수한 균주로 확인된 균주 FT4-4를 동정하기 위해 18S rRNA 유전자 염기서열(서열번호 1)을 분석한 결과, Saccharomyces cerevisiae로 판명되었으며, SeqMatch 프로그램으로 상동성 높은 표준 균주와 비교한 결과, Saccharomyces cerevisiae NRRL Y-12632와 100%의 유사성을 나타내었다(도 1). 최종적으로 본 발명에서 선별한 균주를 사카로마이세스 세레비지애(Saccharomyces cerevisiae) FT4-4로 명명하였으며, 한국미생물보존센터(KCCM, Korean Culture Center of Microorganisms)에 Saccharomyces cerevisiae FT4-4로 2019년 5월 3일자로 기탁하였다(수탁번호: KCCM12522P).As a result of analyzing the 18S rRNA gene base sequence (SEQ ID NO: 1) to identify the strain FT4-4 identified as the best strain through the above Examples, it was found to be Saccharomyces cerevisiae , and compared with a standard strain with high homology by the SeqMatch program As a result, it showed 100% similarity to Saccharomyces cerevisiae NRRL Y-12632 (FIG. 1). Finally, the strain selected in the present invention was named Saccharomyces cerevisiae FT4-4, and was named Saccharomyces cerevisiae FT4-4 at the Korean Culture Center of Microorganisms (KCCM) on 5, 2019. It was deposited on the 3rd of the month (Accession No.: KCCM12522P).
실시예 8. β-글루칸 함량 분석Example 8. β-glucan content analysis
피부생리활성 물질 중 하나인 β-글루칸(glucan)은 글루코오스가 β-(1,3)-D-글리코사이드 결합으로 연결되어 있는 균일 다당류이며, 효모 세포벽의 구성성분 중 가장 많은 양을 차지하고 있다. β-글루칸은 항암, 항콜레스테롤, 면역증강 및 피부 재생 등과 같은 여러 가지 생리활성 촉진 효과가 있다고 알려져있다. 특히, 효모로부터 얻어지는 β-글루칸은 피부를 보호하고 피부 손상 시 피부를 재생시키는 역할을 하며, 인체 내에서 면역시스템을 강화하는데 중요한 역할을 하는 것으로 알려져있다. 이에 본 발명자는 최종 선별 균주 FT4-4에서 생산된 β-글루칸 함량을 Yeast β-glucan kit를 사용하여 분석한 결과, 세포건조무게(g) 당 28.31 ㎎으로 확인되었다. β-glucan, one of the physiologically active substances for skin, is a homogeneous polysaccharide in which glucose is linked by a β-(1,3)-D-glycosidic bond, and occupies the largest amount among the components of the yeast cell wall. β-glucan is known to have various physiological activity promoting effects such as anticancer, anticholesterol, immune enhancement and skin regeneration. In particular, β-glucan obtained from yeast plays a role in protecting the skin and regenerating the skin in case of skin damage, and is known to play an important role in strengthening the immune system in the human body. Accordingly, the present inventors analyzed the content of β-glucan produced in the final selection strain FT4-4 using the Yeast β-glucan kit, and as a result, it was confirmed to be 28.31 mg per cell dry weight (g).
실시예 9. 선별 균주의 균체성장 측정Example 9. Cell growth measurement of selected strains
최종 선별 균주 FT4-4의 배양시간에 따른 건조 균체량의 변화를 조사하였다. 균체의 성장은 유도기(lag phase)가 0~8시간이었으며 정지기(stationary phase)는 12~16시간이었다. 균체량은 16시간에 3.1647 g/L를 기록하였고 이후 균체량이 서서히 증가허거나 감소하는 형태인 대수기(log phase)를 나타내었다. 균체량과 비교를 위한 생균수도 동일한 패턴으로 나타나는 것을 확인하였다(도 2). Changes in the dry cell mass according to the incubation time of the final selected strain FT4-4 were investigated. The growth of the cells had a lag phase of 0-8 hours and a stationary phase of 12-16 hours. The cell mass recorded 3.1647 g/L at 16 hours, and then showed a log phase in which the cell mass gradually increased or decreased. It was confirmed that the cell mass and the number of viable cells for comparison appeared in the same pattern (FIG. 2).
실시예 10. 선별 균주의 알코올 내성, 당 내성 및 아황산 내성 분석Example 10. Analysis of alcohol tolerance, sugar tolerance and sulfurous acid tolerance of selected strains
포도 와인의 저장 기간 및 알코올 발효 능력을 증진시키기 위해서 고농도의 알코올, 글루코스 및 아황산이 와인에 첨가되므로, 이들에 대한 저항성은 와인 제조용 효모로서 필수 요소 중 하나이다. 본 발명에서 최종 선별된 FT4-4 균주의 산업용 효모로서의 가능성을 확인하기 위하여 알코올, 당 및 아황산 내성에 대한 분석을 수행하였다. Since high concentrations of alcohol, glucose and sulfurous acid are added to wine to enhance the storage period and alcoholic fermentation ability of grape wine, resistance to these is one of the essential elements as yeast for wine making. In order to confirm the potential of the FT4-4 strain finally selected in the present invention as an industrial yeast, an analysis for alcohol, sugar and sulfurous acid resistance was performed.
FT4-4의 알코올 내성을 조사하기 위해서 무수에탄올 0, 8, 14 및 20%를 일반 효모 배양 배지인 YPD 액체배지에 첨가하여 건조 균체량을 측정하였다. 그 결과, 알코올 8%를 첨가했을 때에는 대조구(4.69 g/L)에 비하여 건조 균체량이 3.81 g/L로 감소하였으며, 고농도의 에탄올을 첨가했을 때에는 균체가 거의 생장하지 못하는 것을 확인하였다(도 3A). 이는 초기의 낮은 당 농도와 높은 알코올 농도에서는 사카로마이세스 세레비지애가 거의 생장하지 못한다는 이전의 보고와 일치하였다. In order to investigate the alcohol resistance of FT4-4, 0, 8, 14, and 20% of absolute ethanol were added to YPD liquid medium, which is a general yeast culture medium, and the dry cell mass was measured. As a result, when 8% of alcohol was added, the dry cell mass was reduced to 3.81 g/L compared to the control (4.69 g/L), and it was confirmed that almost no cells were grown when high concentration of ethanol was added (FIG. 3A) . This is consistent with the previous report that Saccharomyces cerevisiae hardly grew in the initial low sugar concentration and high alcohol concentration.
FT4-4의 당 내성의 결과는 도 3B와 같으며 대조구인 YPD 액체배지의 균체량 4.55 g/L보다 30% 글루코스를 첨가한 실험구에서는 균체량이 10.51 g/L로 약 2배가량 크게 증가하였고, 40%와 50%의 글루코스가 첨가된 실험구에서도 각각 7.94 g/L와 5.69 g/L로 대조구보다 균체량이 증가하여 FT4-4가 당 내성이 우수한 것을 확인하였다. The results of the sugar tolerance of FT4-4 are the same as in Figure 3B, and in the experimental group in which 30% glucose was added compared to 4.55 g/L of the YPD liquid medium as a control, the cell mass was increased by about 2 times to 10.51 g/L, In the experimental group to which 40% and 50% glucose was added, the cell mass was increased to 7.94 g/L and 5.69 g/L, respectively, compared to the control group, confirming that FT4-4 had excellent sugar tolerance.
아황산은 식품 및 음료와 약품 보존의 용도로 첨가되는 물질로 산화 방지 및 항균 효과와 갈변 방지 등의 효과를 나타낸다. 따라서 와인의 제조에도 산화 방지와 선택적 유해 미생물 억제를 위해 아황산이 사용되고 있어, 와인 제조용 효모는 이에 대한 내성을 가질 필요가 있다. 현재 국내 식품 규격상 350 ㎎/L의 첨가 허용 규격에 맞추어 100, 200 및 300 ppm의 아황산을 첨가하여 FT4-4 균주의 아황산 내성을 조사하였다. 그 결과, 첨가된 아황산의 농도가 높아져도 FT4-4의 균체량은 큰 영향을 받지 않아, 우수한 아황산 내성을 가진 효모임을 확인하였다(도 3C). Sulfurous acid is a substance added for the purpose of preserving food, beverages, and pharmaceuticals, and has effects such as anti-oxidation, antibacterial and browning prevention. Therefore, sulfurous acid is used to prevent oxidation and selectively inhibit harmful microorganisms in the production of wine, and yeast for wine production needs to have resistance to it. According to the current domestic food standards, sulfurous acid resistance of FT4-4 strain was investigated by adding 100, 200 and 300 ppm of sulfurous acid in accordance with the allowable addition of 350 mg/L. As a result, even when the concentration of added sulfurous acid increased, the cell mass of FT4-4 was not significantly affected, confirming that the yeast had excellent sulfurous acid resistance (FIG. 3C).
<110> Microbial Institute for Fermentation Industry <120> Saccharomyces cerevisiae FT4-4 strain having antioxidant activity and tyrosinase inhibitory activity isolated from blueberry and uses thereof <130> PN20179 <160> 3 <170> KoPatentIn 3.0 <210> 1 <211> 1730 <212> DNA <213> Saccharomyces cerevisiae <400> 1 atgtctaagt ataagcaatt tatacagtga aactgcgaat ggctcattaa atcagttatc 60 gtttatttga tagttccttt actacatggt ataactgtgg taattctaga gctaatacat 120 gcttaaaatc tcgacccttt ggaagagatg tatttattag ataaaaaatc aatgtcttcg 180 gactctttga tgattcataa taacttttcg aatcgcatgg ccttgtgctg gcgatggttc 240 attcaaattt ctgccctatc aactttcgat ggtaggatag tggcctacca tggtttcaac 300 gggtaacggg gaataagggt tcgattccgg agagggagcc tgagaaacgg ctaccacatc 360 caaggaaggc agcaggcgcg caaattaccc aatcctaatt cagggaggta gtgacaataa 420 ataacgatac agggcccatt cgggtcttgt aattggaatg agtacaatgt aaatacctta 480 acgaggaaca attggagggc aagtctggtg ccagcagccg cggtaattcc agctccaata 540 gcgtatatta aagttgttgc agttaaaaag ctcgtagttg aactttgggc ccggttggcc 600 ggtccgattt tttcgtgtac tggatttcca acggggcctt tccttctggc taaccttgag 660 tccttgtggc tcttggcgaa ccaggacttt tactttgaaa aaattagagt gttcaaagca 720 ggcgtattgc tcgaatatat tagcatggaa taatagaata ggacgtttgg ttctattttg 780 ttggtttcta ggaccatcgt aatgattaat agggacggtc gggggcatca gtattcaatt 840 gtcagaggtg aaattcttgg atttattgaa gactaactac tgcgaaagca tttgccaagg 900 acgttttcat taatcaagaa cgaaagttag gggatcgaag atgatcagat accgtcgtag 960 tcttaaccat aaactatgcc gactagggat cgggtggtgt ttttttaatg acccactcgg 1020 caccttacga gaaatcaaag tctttgggtt ctggggggag tatggtcgca aggctgaaac 1080 ttaaaggaat tgacggaagg gcaccaccag gagtggagcc tgcggcttaa tttgactcaa 1140 cacggggaaa ctcaccaggt ccagacacaa taaggattga cagattgaga gctctttctt 1200 gattttgtgg gtggtggtgc atggccgttc ttagttggtg gagtgatttg tctgcttaat 1260 tgcgataacg aacgagacct taacctacta aatagtggtg ctagcatttg ctggttatcc 1320 acttcttaga gggactatcg gtttcaagcc gatggaagtt tgaggcaata acaggtctgt 1380 gatgccctta gacgttctgg gccgcacgcg cgctacactg acggagccag cgagtctaac 1440 cttggccgag aggtcttggt aatcttgtga aactccgtcg tgctggggat agagcattgt 1500 aattattgct cttcaacgag gaattcctag taagcgcaag tcatcagctt gcgttgatta 1560 cgtccctgcc ctttgtacac accgcccgtc gctagtaccg attgaatggc ttagtgaggc 1620 ctcaggatct gcttagagaa gggggcaact ccatctcaga gcggagaatt tggacaaact 1680 tggtcattta gaggaactaa aagtcgtaac aaggtttccg taggtgaacc 1730 <210> 2 <211> 19 <212> DNA <213> Artificial Sequence <220> <223> primer <400> 2 tccgtaggtg aacctgcgg 19 <210> 3 <211> 21 <212> DNA <213> Artificial Sequence <220> <223> primer <400> 3 tcctcccgct tattgatatg c 21 <110> Microbial Institute for Fermentation Industry <120> Saccharomyces cerevisiae FT4-4 strain having antioxidant activity and tyrosinase inhibitory activity isolated from blueberry and uses it <130> PN20179 <160> 3 <170> KoPatentIn 3.0 <210> 1 <211> 1730 <212> DNA <213> Saccharomyces cerevisiae <400> 1 atgtctaagt ataagcaatt tatacagtga aactgcgaat ggctcattaa atcagttatc 60 gtttatttga tagttccttt actacatggt ataactgtgg taattctaga gctaatacat 120 gcttaaaatc tcgacccttt ggaagagatg tatttattag ataaaaaatc aatgtcttcg 180 gactctttga tgattcataa taacttttcg aatcgcatgg ccttgtgctg gcgatggttc 240 attcaaattt ctgccctatc aactttcgat ggtaggatag tggcctacca tggtttcaac 300 gggtaacggg gaataagggt tcgattccgg agagggagcc tgagaaacgg ctaccacatc 360 caaggaaggc agcaggcgcg caaattaccc aatcctaatt cagggaggta gtgacaataa 420 ataacgatac agggcccatt cgggtcttgt aattggaatg agtacaatgt aaatacctta 480 acgaggaaca attggagggc aagtctggtg ccagcagccg cggtaattcc agctccaata 540 gcgtatatta aagttgttgc agttaaaaag ctcgtagttg aactttgggc ccggttggcc 600 ggtccgattt tttcgtgtac tggatttcca acggggcctt tccttctggc taaccttgag 660 tccttgtggc tcttggcgaa ccaggacttt tactttgaaa aaattagagt gttcaaagca 720 ggcgtattgc tcgaatatat tagcatggaa taatagaata ggacgtttgg ttctattttg 780 ttggtttcta ggaccatcgt aatgattaat agggacggtc gggggcatca gtattcaatt 840 gtcagaggtg aaattcttgg atttattgaa gactaactac tgcgaaagca tttgccaagg 900 acgttttcat taatcaagaa cgaaagttag gggatcgaag atgatcagat accgtcgtag 960 tcttaaccat aaactatgcc gactagggat cgggtggtgt ttttttaatg acccactcgg 1020 caccttacga gaaatcaaag tctttgggtt ctggggggag tatggtcgca aggctgaaac 1080 ttaaaggaat tgacggaagg gcaccaccag gagtggagcc tgcggcttaa tttgactcaa 1140 cacggggaaa ctcaccaggt ccagacacaa taaggattga cagattgaga gctctttctt 1200 gattttgtgg gtggtggtgc atggccgttc ttagttggtg gagtgatttg tctgcttaat 1260 tgcgataacg aacgagacct taacctacta aatagtggtg ctagcatttg ctggttatcc 1320 acttcttaga gggactatcg gtttcaagcc gatggaagtt tgaggcaata acaggtctgt 1380 gatgccctta gacgttctgg gccgcacgcg cgctacactg acggagccag cgagtctaac 1440 cttggccgag aggtcttggt aatcttgtga aactccgtcg tgctggggat agagcattgt 1500 aattattgct cttcaacgag gaattcctag taagcgcaag tcatcagctt gcgttgatta 1560 cgtccctgcc ctttgtacac accgcccgtc gctagtaccg attgaatggc ttagtgaggc 1620 ctcaggatct gcttagagaa gggggcaact ccatctcaga gcggagaatt tggacaaact 1680 tggtcattta gaggaactaa aagtcgtaac aaggtttccg taggtgaacc 1730 <210> 2 <211> 19 <212> DNA <213> Artificial Sequence <220> <223> primer <400> 2 tccgtaggtg aacctgcgg 19 <210> 3 <211> 21 <212> DNA <213> Artificial Sequence <220> <223> primer <400> 3 tcctcccgct tattgatatg c 21
Claims (6)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020200122067A KR20220039942A (en) | 2020-09-22 | 2020-09-22 | Saccharomyces cerevisiae FT4-4 strain having antioxidant activity and tyrosinase inhibitory activity isolated from blueberry and uses thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020200122067A KR20220039942A (en) | 2020-09-22 | 2020-09-22 | Saccharomyces cerevisiae FT4-4 strain having antioxidant activity and tyrosinase inhibitory activity isolated from blueberry and uses thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR20220039942A true KR20220039942A (en) | 2022-03-30 |
Family
ID=80948057
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020200122067A Ceased KR20220039942A (en) | 2020-09-22 | 2020-09-22 | Saccharomyces cerevisiae FT4-4 strain having antioxidant activity and tyrosinase inhibitory activity isolated from blueberry and uses thereof |
Country Status (1)
| Country | Link |
|---|---|
| KR (1) | KR20220039942A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115710556A (en) * | 2022-12-16 | 2023-02-24 | 陈盈如 | Saccharomyces cerevisiae and application thereof |
| CN115927024A (en) * | 2022-12-16 | 2023-04-07 | 陈盈如 | Saccharomyces cerevisiae and its application |
| KR20240002363A (en) | 2022-06-29 | 2024-01-05 | 한국식품연구원 | Composition for anti-oxidant and skin-whitening cantaining Saccharomyces boulardii as an active ingredient |
-
2020
- 2020-09-22 KR KR1020200122067A patent/KR20220039942A/en not_active Ceased
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20240002363A (en) | 2022-06-29 | 2024-01-05 | 한국식품연구원 | Composition for anti-oxidant and skin-whitening cantaining Saccharomyces boulardii as an active ingredient |
| CN115710556A (en) * | 2022-12-16 | 2023-02-24 | 陈盈如 | Saccharomyces cerevisiae and application thereof |
| CN115927024A (en) * | 2022-12-16 | 2023-04-07 | 陈盈如 | Saccharomyces cerevisiae and its application |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR101353054B1 (en) | fermented product and manufacturing method thereof, food composition cosmetic and compositon | |
| KR20120061733A (en) | Cosmetic composition for whitening containing green tea extract | |
| KR101686112B1 (en) | Composition of culture medium for cultivation of Lactobacillus, ginseng berry-fermented extracts comprising thereof and cosmetic composition for improving skin conditions | |
| KR101628756B1 (en) | Novel Lactobacillus pentosus NEO 1 and extracts from ginseng-fermented products using Lactobacillus pentosus NEO 1 and manufacturing method thereof | |
| KR101875001B1 (en) | Lactobacillus fermentum GFCSJ and cacao nibs Fermented extract Manufactured Using Thereof | |
| KR20220039942A (en) | Saccharomyces cerevisiae FT4-4 strain having antioxidant activity and tyrosinase inhibitory activity isolated from blueberry and uses thereof | |
| KR101968242B1 (en) | Lactobacillus brevis ami-1109 and use thereof | |
| CN114073659B (en) | Preparation and application of fermentation product of lactobacillus paracasei from distillers' grains of chicken feet wine in Pan-Mahala region | |
| CN114081862B (en) | Preparation and application of Saccharomyces cerevisiae fermentation product from highland barley wine distiller's yeast in Pan-Himalaya region | |
| CN118048423A (en) | Multi-effect bird's nest peptide and preparation method and application thereof | |
| KR20160074116A (en) | Cosmetic composition containing Crataegis fructus fermented extract | |
| KR102133721B1 (en) | functional food composition for antioxidant effect comprising fermented permission leaf | |
| KR20200083710A (en) | Composition containing an fermentation extract of zanthoxylum schinifolium as an active ingredient and its use | |
| CN112870130A (en) | Preparation method of eucommia pollen fermentation liquor and application of eucommia pollen fermentation liquor in cosmetics | |
| KR101194226B1 (en) | Cosmetic composition for antioxidant and whitening effects having fermented paprika extract and manufacturing method thereof | |
| KR102606937B1 (en) | Lactobacillus brevis GFC0707P and Epilobium angustifolium Fermented extract Manufactured Using Thereof | |
| KR20190037436A (en) | Cosmetic composition including fermented water lily extract and method for manufacturing the same | |
| KR101181269B1 (en) | Exopolysaccharides with antioxidant and antiaging activity produced by Bacillus sp. strains isolated from kimchi, a fermented korean food and the method for manufacturing the same | |
| KR101918673B1 (en) | A novel marine-derived bacterium, and cosmetic compositions using the same | |
| KR20230060310A (en) | Antibacterial and antioxidant composition comprising fermented Centella asiatica extract fermented by inoculating Bacillus safensis strain | |
| CN114317617A (en) | Preparation method and application of triple probiotic fermented compound with anti-wrinkle effect | |
| KR101906309B1 (en) | Lactobacillus curvatus GFC-AM5, Sauerkraut Fermented Extract and The Cosmetic Composition Including The Same | |
| KR101761771B1 (en) | Method for fermenting Broussonetia plant or the extract thereof, the fermented extracts thereby and the cosmetic composition containing the same | |
| KR102457506B1 (en) | Lactobacillus pentosus SRCM216971 strain having antimicrobial activity against acne-causing strain and uses thereof | |
| KR101817776B1 (en) | Lespedeza cuneata G.Don Fermented extract Using Lactobacillus pentosus-GFC LP and Method for Preparing the Same |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 20200922 |
|
| PA0201 | Request for examination | ||
| PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20220126 Patent event code: PE09021S01D |
|
| PG1501 | Laying open of application | ||
| E601 | Decision to refuse application | ||
| PE0601 | Decision on rejection of patent |
Patent event date: 20220331 Comment text: Decision to Refuse Application Patent event code: PE06012S01D Patent event date: 20220126 Comment text: Notification of reason for refusal Patent event code: PE06011S01I |